By www.reportprimer.com
Global Non-muscle Invasive Bladder Cancer Therapeutics Market Research Report 2024 Story
113
$ 2900
Non-muscle Invasive Bladder Cancer Therapeutics Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
F. Hoffmann-La Roche Ltd. Bristol-Myers Squibb Company AstraZeneca Pfizer Inc. GlaxoSmithKline plc. Sanofi S.A. Novartis AG Eli Lilly and Company Merck & Co. Viventia Bio Inc. Celgene Corporation Spectrum Pharmaceuticals, Inc. Herantis Pharma Plc. Taris Biomedical LLC Prometic Life Sciences Inc. Telormediz S.A. Heat Biologics Altor BioScience Ferring B.V. Cold Genesys Inc.